EVALUATION OF DIAGNOSTIC SIGNIFICANCE OF PELVIC MRI IN PROSTATE CANCER PATIENTS


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Accurate staging of prostate cancer is a prerequisite to forecast disease progression and to guide surgery planning. In current clinical practice, contrast-enhanced MRI is one of the imaging tools for improving the evaluation of prostate cancer patients. To assess the diagnostic value of MRI a retrospective study in a real clinical practice setting was conducted. Preoperative M RI images were compared to postoperative pathological findings after radical prostatectomy. Accuracy of 85,3% was found in detection of seminal vesicle involvement and 65% in extracapsular extension. Specificities achieved 93,9% and 98,5%, respectively.

Texto integral

Acesso é fechado

Sobre autores

P. Rasner

Moscow State Medical and Dental University n.a. A.I. Evdokimov

Email: dr.rasner@gmail.com
Ph.D., Assistant Professor of Urology Moscow

D. Kotenko

Moscow State Medical and Dental University n.a. A.I. Evdokimov

Department of Urology Moscow

K. Kolontarev

Moscow State Medical and Dental University n.a. A.I. Evdokimov

Department of Urology Moscow

B. Brodeckiy

Moscow State Medical and Dental University n.a. A.I. Evdokimov

Department of Urology Moscow

D. Pushkar

Moscow State Medical and Dental University n.a. A.I. Evdokimov

Department of Urology Moscow

Bibliografia

  1. Gossmann A., Okuhata Y., Shames D.M., Helbich T.H., Roberts T.P., 10. Wendland M.F., Huber S., Brasch R.C. Prostate Cancer Tumor Grade Differentiation with Dynamic Contrast-enhanced MR Imaging in the Rat: Comparison of Macromolecular and Small- Molecular Contrast Media-Preliminary Experience. Radiology. 1999; 213(1): 265-272.
  2. Dikaios N., Alkalbani J., Sidhu H.S., Fujiwara T., Abd-Alazeez M., Kirkham A., Allen C., Ahmed H., Emberton M, Freeman A., Halligan S, Taylor S., Atkinson D., Punwani S. Logistic regression model for diagnosis of transition zone prostate canceron multi-parametric MRI. Eur. Radiol. 2014; 25(2):523-532.
  3. Кармазановский Г.Г. Оценка диагностической значимости метода («чувствительность», «специфичность», «общая точность»). Анналы хирургической гепатологии. 1997;2:139- 142.
  4. Barentsz J.O., Richenberg J., Clements R., Choyke P., Verma S., Villeirs G., Rouviere O., Logager V., Fйtterer J.J. European Society of Urogenital Radiology. ESUR prostate MR guidelines 2012. Eur. Radiol. 2012;22(4):746-757.
  5. Dickinson L., Ahmed H.U., Allen C. Barentsz J.O., Carey B., Fut- terer J.J., Heijmink S.W., Hoskin P.J., Kirkham A., Padhani A.R., Persad R., Puech P., Punwani S., Sohaib A.S., Tombal B., Villers A., van der Meulen J., Emberton M. Magnetic resonance imaging for the detection, localisation, and characterization of prostate cancer: recommendations from a European consensus meeting. Eur. Urol. 2011;59(4):477-494.
  6. Rouviere O., Hartman R.P., Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution? Eur. Radiol. 2006;16:276- 284.
  7. Cornud F., Flam T., Chauveinc L., Hamida K., Chretien Y., Vieillefond A., Helenon O., Moreau J.F. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology. 2002;224:203-210.
  8. Kozlowski P., Chang S.D., Jones E.C., Berean K.W., Chen H., Goldenberg S.L. Combined Diffusion-Weighted and Dynamic Contrast-Enhanced MRI for Prostate Cancer Diagnosis- Correlation With Biopsy and Histopathology. J. Magn. Reson. Imaging. 2006;24(1):108-113.
  9. Bloch B.N., Furman-Haran E., Helbich T.H., Lenkinski R.E., Degani H., Kratzik C., Susani M., Haitel A., Jaromi S., Ngo L., Rofsky N.M. Prostate Cancer: Accurate Determination of Extracapsular Extension with High-Spatial-Resolution Dynamic Contrast-enhanced and T2-weighted MR Imaging-Initial Results.
  10. Chefchaouni M.C., Flam T., Cornud F., Thiounn N., Belin X., Desligneres S., Zerbib M., Moreau J.L., Debre B. Resultats de’IRM endo-rectaledans la stadification locale du cancer de la prostate. J. Urol. 1996;102:51-55.
  11. Presti J.C., Hricak H., Narayan P.A., Shinohara K., White S., Carroll P.R. Local staging of prostatic carcinoma: comparison of transrectalsonography and endorectal MR imaging. Am. J. Roentgenol. 1996;166:103-108.
  12. Bates T.S., Gillatt D.A., Cavanagh P.M., Speakman M. A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br. J. Urol. 1997;79:927-932.
  13. Ikonen S., Karkkainen P., Kivisaari L., Salo J.O., Taari K., Vehmas T., Tervahartiala P., Rannikko S. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and threedimensional dual-echo, steady-state sequences. Eur. Radiol. 2001;11:236-241.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2015

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies